Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 1999;45:812-817; doi:10.1136/gut.45.6.812
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 1999;45:812-817 ( December )

Article

A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth S A Watsona, T M Morrisa, A Varrob, D Michaelic, A M Smitha

a Academic Unit of Cancer Studies, Department of Surgery, University of Nottingham, UK, b Department of Physiology, University of Liverpool, UK, c Aphton Corporation, California, USA

Correspondence to: Dr S A Watson, Academic Unit of Cancer Studies, Department of Surgery, University of Nottingham, UK.

Accepted for publication 6 July 1999

BACKGROUND---Gastrin is a growth factor for established tumours.
AIMS---To investigate the therapeutic effect of antibodies, raised against the Gastrimmune immunogen, which neutralise the glycine extended and carboxy amidated forms of gastrin 17 in two human gastric cancer models.
METHODS---MGLVA1 cells (which have a gastrin autocrine/paracrine phenotype) and ST16 cells (which have an endocrine phenotype) were injected into the peritoneal cavity of SCID mice. Peritoneal tumours, ascites, and cachexia formation occurred, with the monitored endpoint being morbidity.
RESULTS---In MGLVA1 cells, intravenous administration of antibodies raised against Gastrimmune increased the 50% median survived by 25% at three different initial cell seeding concentrations (1 × 106-5 × 105 per mouse). In ST16 cells, the effect of Gastrimmune induced antibodies on time to morbidity was greatest at the lowest cell seeding concentration (5 × 105 cells/mouse) with the 50% median survival increased by 74% and overall survival achieved in 38% of the mice.
CONCLUSIONS---Gastrimmune may have potential therapeutic benefit on gastrin sensitive gastric tumours and may interact with both endocrine and autocrine mediated growth pathways.


Keywords: gastrin; gastric cancer; Gastrimmune; autocrine/paracrine growth


© 1999 by Gut

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs